Doliente, Michelle .

HRN: 05-68-95  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/12/2023
CEFUROXIME 1.5GM (VIAL)
07/12/2023
07/19/2023
IV
1.5
On Call Or
For CS
Checking Final Appropriateness 
07/14/2023
CEFUROXIME 500MG (TAB)
07/14/2023
07/20/2023
PO
500mg
BID
S/P CS FOR CPD
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: